|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effect of grapefruit juice on the pharmacokinetics of tolvaptan, a non-peptide arginine vasopres- sin antagonist, in healthy subjects 显示文摘 | Shoaf SE Mallikaarjun S Bricmont P | 2012 | Eur J Clin Pharmacol2012，68，2： | 1 |
| 2 | Pharmacokinetic and pharmacodynamic interaction between tolvaptan, a non-peptide A VP antagonist, and furosemide or hydrochlorothiazide 显示文摘 | SHOAF S BRAMER S BRICMONT P | 2007 | J Cardiovasc Pharmacol2007，50，2： | 1 |
| 3 | Pharma- cokinetics and pharmacodynamics of single-dose oral tolvaptan in fasted and non-fasted states in healthy caucasian and japanese male subjects 显示文摘 | SHOAF S E KIM S R BRICMONT P | 2012 | Eur J Clin Pharmacol2012，，68： | 1 |
| 4 | Pharmacokinetic and pharma- codynamic interaction between tolvaptan,a non-peptide AVP antagonist, and furosemide orhydrochlomthiazide显示文摘 | Shoal S E Bramer S L Bricmont P | 2007 | J Cardiovasc Pharmacol2007，50，2： | 1 |
| 5 | Pharmacokinetics,pharmacodynamics,and safety of tolvaptan,a nonpeptide AVP antagonist,during ascending single-dose studies in healthy subjects显示文摘 | Shoaf SE Wang Z Bricmont P | 2007 | J Clin Pharmacol2007，47，12： | 1 |
| 6 | Pharmacokinetic and phar- macodynamie interaction between tolvaptan, a non - peptide AVP an- tagonist, and furosemide orhydroehlorotbiazide 显示文摘 | Shoal SE Bramer SL Bricmont P | 2007 | J Cardiovasc Pharmacol2007，50，： | 1 |
| 7 | Effect of grapefruit juice on the pharmacokinetics of tolvaptan, a non-peptide arginine vasopressin antagonist,in healthy subjects显示文摘 | Shoaf SE Mallikaarjun S Bricmont P | 2012 | Eur J Clin Pharmacol2012，68，2： | 1 |
| 8 | Pharmacoki- netics, pharmacodynamics, and safety of tolvaptan, a nonpeptide AVP antagonist, during ascending sin- gle-dose studies in healthy subjects显示文摘 | Shoaf SE Wang Z Bricmont P | 2007 | J Clin Phar- maeol2007，47，12： | 1 |
| 9 | Pharma cokinetic and pharmacodynamic interaction between tolvaptan, a non-peptide AVP antagonist, and furo- semide or hydrochlorothiazide 显示文摘 | Shoal SE Bramer SL Bricmont P | 2007 | J Cardiovasc Pharmacol2007，50，2： | 1 |
| 10 | Pharmocokine- ties, pharmaeodynamies, and safety of tolvaptan, a nonpeptide AVP antagonist, during ascending single-dose studies in healthy subjects显示文摘 | SHOAF SE WANG Z BRICMONT P | 2007 | J Clin Pharmacol2007，47，12： | 1 |
| 11 | Pharmoco- kinetic and pharmacodynamic interaction between tolvaptan, a non-peptide AVP antagonist, and furosemide or hydrochloro- thiazide显示文摘 | SHOAF SE BRAMER SL BRICMONT P | 2007 | J Cardiovasc Pharmacol2007，50，2： | 1 |
| 12 | Pharmacokinetics, pharmacodynamics, and safety of tolvaptan, nonpeptide AVP antagonist, during ascending single-dose studies in healthy subjects 显示文摘 | SHOAF S WANG Z BRICMONT P | 2007 | JClinPharmacol2007，47，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员